Nutriterra is a revolution in omega-3 nutrition, recognized as the most complex biotechnology successfully brought to market.
REQUEST A SAMPLE
.avif)
Australian researchers at CSIRO developed an innovative process to transfer the omega-3 producing genetics of microalgae into canola.
Nuseed scientists collaborated with CSIRO to transform the concept of plant-based omega-3 production into a commercial reality.
.avif)
Canola (Brassica napus) was chosen for its unique oil profile, capable of producing long-chain polyunsaturated fatty acids (LCPUFAs) from the crop's natural oleic acid.
Additionally, canola is cultivated on five continents, with a global annual production of 90 million metric tonnes, making it an ideal choice for sustainable, scalable production of DHA and EPA.
In Phase I and Phase II clinical trials, Nutriterra significantly improved omega-3 index, omega-3 levels, and DHA levels in just 4 weeks.
Participants consuming Nutriterra on a daily basis saw significantly improved DHA blood levels and omega-6 to omega-3 ratios, which have been found to support brain health and reduce cardiovascular health risks.
+
33% increase in DHA levels in 4 weeks
+
22% increase in omega-3 whole blood score
+
19% increase in omega-3 index
+
19% increase in DHA levels
+
12% increase in omega-3 whole blood score
+
10% increase in omega-3 index
+
8% increase in DHA levels
+
4% increase in omega-3 whole blood score
+
4% increase in omega-3 index
After 16 weeks, all study participants had further raised their DHA levels, with high dose levels by an average of 45%, medium dose by 23%, and low dose by 11%.
request a sample
.avif)
Nutriterra’s DHA, EPA, and ALA content offer a variety of structure and function claims under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Depending on your product, one or more of these claims may be used on your packaging and promotional materials when utilizing Nutriterra. Request a copy of our claims sheet today.
.svg)
